Eleftheria Zeggini (Greek: Ελευθερία Ζεγγίνη) is a director of the institute of translational genomics in Helmholtz Zentrum München and a professor at the Technical University of Munich (TUM).

[4][1][5] Previously she served as a research group leader at the Wellcome Trust Sanger Institute from 2008 to 2018[6][7] and an honorary professor in the department of health sciences at the University of Leicester in the UK.

[12][13] Following her PhD, Zeggini was a postdoctoral researcher at the Wellcome Trust Centre for Human Genetics at the University of Oxford where she later became a Wellcome Trust research career development fellow.

[6] As of 2020[update], according to Google scholar[1] and Scopus[10] her most cited work has been published in Science[14][15] and Nature Genetics.

[18][19] In a study published in 2017, her team reported the discovery of a genetic variant in Mediterranean Cretan villagers that protected them against the harmful effects of 'bad' fats and cholesterol as well as decrease the risk of cardiovascular disease.